These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25649860)

  • 1. Long-term epidemiology of multiple sclerosis in the Northern Seville District.
    Izquierdo G; Venegas A; Sanabria C; Navarro G
    Acta Neurol Scand; 2015 Aug; 132(2):111-7. PubMed ID: 25649860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological study of multiple sclerosis in La Rioja.
    Bártulos Iglesias M; Marzo Sola ME; Estrella Ruiz LA; Bravo Anguiano Y
    Neurologia; 2015; 30(9):552-60. PubMed ID: 24975346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of multiple sclerosis in Santiago de Compostela (Spain).
    Costa Arpín E; Naveiro Soneira J; Lema Bouzas M; González Quintela A; Prieto González JM
    Acta Neurol Scand; 2020 Sep; 142(3):267-274. PubMed ID: 32392359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.
    O'Connell K; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2017 Apr; 13():75-80. PubMed ID: 28427707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of multiple sclerosis in Health District III, Murcia, Spain.
    Candeliere-Merlicco A; Valero-Delgado F; Martínez-Vidal S; Lastres-Arias Mdel C; Aparicio-Castro E; Toledo-Romero F; Villaverde-González R
    Mult Scler Relat Disord; 2016 Sep; 9():31-5. PubMed ID: 27645340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis in Móstoles, central Spain.
    Benito-León J; Martin E; Vela L; Villar ME; Felgueroso B; Marrero C; Guerrero A; Ruiz-Galiana J
    Acta Neurol Scand; 1998 Oct; 98(4):238-42. PubMed ID: 9808272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of multiple sclerosis in the sanitary district of Calatayud, Northern Spain: is Spain a zone of high risk for this disease?
    Pina MA; Ara JR; Modrego PJ; Morales F; Capablo JL
    Neuroepidemiology; 1998; 17(5):258-64. PubMed ID: 9705585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of multiple sclerosis in the province of Teruel, Spain.
    Modrego Pardo PJ; Latorre MA; López A; Errea JM
    J Neurol; 1997 Mar; 244(3):182-5. PubMed ID: 9050959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis in Gijon health district, Asturias, northern Spain.
    Uria DF; Abad P; Calatayud MT; Virgala P; Diaz A; Chamizo C; Dean G
    Acta Neurol Scand; 1997 Dec; 96(6):375-9. PubMed ID: 9449475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early onset multiple sclerosis: a longitudinal study.
    Boiko A; Vorobeychik G; Paty D; Devonshire V; Sadovnick D;
    Neurology; 2002 Oct; 59(7):1006-10. PubMed ID: 12370453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiple sclerosis incidence in the Alcoi Health district. 12-year-long study (1986-1997)].
    Mallada-Frechín J; Matías-Guiu Guía J; Martín R; López-Arlandis JM; Camacho-Cuartero JM; Beltrán I; Moltó JM; Falip R; Abellán-Miralles I
    Rev Neurol; 2000 Jun 16-30; 30(12):1128-31. PubMed ID: 10935236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology and clinical evolutionary aspects of multiple sclerosis in Navarra].
    Antón Aranda E; Martínez-Lage JM; Maraví Petri E; Gállego Culleré J; de Castro P; Villanueva Eusa JA
    Neurologia; 1991 May; 6(5):160-9. PubMed ID: 1873044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of multiple sclerosis in the Sanitary District of Vélez-Málaga, southern Spain.
    Fernández O; Luque G; San Román C; Bravo M; Dean G
    Neurology; 1994 Mar; 44(3 Pt 1):425-9. PubMed ID: 8145909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and incidence of multiple sclerosis in central Poland, 2010-2014.
    Brola W; Sobolewski P; Flaga S; Fudala M; Szczuchniak W; Stoiński J; Rosołowska A; Wójcik J; Kapica-Topczewska K; Ryglewicz D
    BMC Neurol; 2016 Aug; 16(1):134. PubMed ID: 27516084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact on healthcare resource utilization of multiple sclerosis in Spain.
    Sicras-Mainar A; Ruíz-Beato E; Navarro-Artieda R; Maurino J
    BMC Health Serv Res; 2017 Dec; 17(1):854. PubMed ID: 29284493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity and metabolic syndrome in patients with multiple sclerosis from Asturias and Catalonia, Spain.
    Sicras-Mainar A; Ruíz-Beato E; Navarro-Artieda R; Maurino J
    BMC Neurol; 2017 Jul; 17(1):134. PubMed ID: 28716070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical longitudinal study of multiple sclerosis in Cantabria, Spain.
    Morís G; Berciano J; Miró J
    Neurologia; 2003 Dec; 18(10):723-30. PubMed ID: 14648348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High work absence around time of diagnosis of multiple sclerosis is associated with fatigue and relapse rate.
    Doesburg D; Vennegoor A; Uitdehaag BMJ; van Oosten BW
    Mult Scler Relat Disord; 2019 Jun; 31():32-37. PubMed ID: 30901702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of multiple sclerosis in the Scottish Highlands: Prevalence, incidence and time to confirmed diagnosis and treatment initiation.
    Carod-Artal FJ
    Mult Scler Relat Disord; 2021 Jan; 47():102657. PubMed ID: 33302230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.